Cargando…
Implementation of the plasma MYCN/NAGK ratio to detect MYCN amplification in patients with neuroblastoma
Detection of amplification of the MYCN gene is essential for determining optimal treatment and estimating prognosis of patients with neuroblastoma (NB). DNA FISH with neuroblastoma tissues or patient‐derived bone marrow cells is the standard clinical practice for the detection of MYCN amplification....
Autores principales: | Su, Yan, Wang, Lijun, Zhao, Qian, Yue, Zhixia, Zhao, Wen, Wang, Xisi, Duan, Chao, Jin, Mei, Zhang, Dawei, Chen, Shenglan, Yin, Jianfeng, Qiu, Lihua, Cheng, Xianfeng, Xu, Zhong, Ma, Xiaoli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607162/ https://www.ncbi.nlm.nih.gov/pubmed/32896084 http://dx.doi.org/10.1002/1878-0261.12794 |
Ejemplares similares
-
MYCN Amplifications and Metabolic Rewiring in Neuroblastoma
por: Pouliou, Marialena, et al.
Publicado: (2023) -
Therapeutic potential of targeting MYCN: A case series report of neuroblastoma with MYCN amplification
por: Huang, Can, et al.
Publicado: (2020) -
MYCN amplification and ATRX mutations are incompatible in neuroblastoma
por: Zeineldin, Maged, et al.
Publicado: (2020) -
MYCN is amplified during S phase, and c-myb is involved in controlling MYCN expression and amplification in MYCN-amplified neuroblastoma cell lines
por: Aygun, Nevim, et al.
Publicado: (2019) -
CCNB1IP1 prevents ubiquitination‐mediated destabilization of MYCN and potentiates tumourigenesis of MYCN‐amplificated neuroblastoma
por: Zhou, Yang, et al.
Publicado: (2023)